文献速递儿科与产科急症重症综合管理与镇静镇痛

儿科急诊一氧化二氮程序化镇静方案的安全性与有效性:十年结局

Safety and efficacy of a nitrous oxide procedural sedation programme in a paediatric emergency department: a decade of outcomes.
PubMed 文献 · Emerg Med J · 2024-01-22
一句话结论十年831例儿科急诊一氧化二氮镇静成功率为97.4%,联合鼻内芬太尼不提高成功率但增加呕吐(RR 1.8)。

该研究回顾性分析了儿科急诊10年(2011-2021)前瞻性镇静登记数据,共831例一氧化二氮程序化镇静,其中358例(43.1%)联合鼻内芬太尼,728例(87.6%)由护士实施。镇静成功809例(97.4%),密歇根大学镇静量表的中位镇静深度为1分(IQR 1-2)。联合鼻内芬太尼组镇静评分更高(2 vs 1,p<0.001)且呕吐增加(RR 1.8,95%CI 1.3-2.5),但镇静成功率无差异;无论一氧化二氮浓度或是否联合芬太尼,均未报告严重不良事件。

要点

  • 831例一氧化二氮程序化镇静中,镇静成功809例(97.4%),中位镇静深度为密歇根大学镇静量表1分(IQR 1-2)。
  • 联合鼻内芬太尼组较单用一氧化二氮组镇静评分更高(2 vs 1,p<0.001),呕吐风险增加(RR 1.8,95%CI 1.3-2.5),镇静成功率无差异。
  • 无论一氧化二氮浓度或是否联合鼻内芬太尼,均未报告严重不良事件(包括血氧饱和度下降、呼吸暂停、误吸、心动过缓或低血压)。
  • 呕吐发生113例(13.6%),与较高一氧化二氮浓度及使用鼻内芬太尼相关,与禁食状态无关。
  • 医生实施与护士实施镇静的不良事件(RR 0.98,95%CI 0.97-1.04)和成功率(RR 0.93,95%CI 0.56-1.7)无差异。

适用人群与场景

  • 儿科急诊(PED)接受程序化镇静的患儿,具体纳入与排除标准原文未述。

诊断标准与关键阈值

  • 镇静深度采用密歇根大学镇静量表评估,中位评分为1分(IQR 1-2)。

处置流程与药物剂量

  • 一氧化二氮单独或联合鼻内芬太尼用于儿科急诊程序化镇静,具体剂量、给药方案原文未述。

红旗征与不能漏的情况

  • 呕吐发生113例(13.6%),与较高一氧化二氮浓度及使用鼻内芬太尼相关。

研究设计与关键结果

  • 研究类型为对儿科急诊镇静登记的前瞻性收集数据进行回顾性分析,纳入2011-2021年共831例一氧化二氮程序化镇静,其中358例(43.1%)联合鼻内芬太尼,728例(87.6%)由护士实施镇静。
  • 镇静成功809例(97.4%),中位镇静深度为密歇根大学镇静量表1分(IQR 1-2)。
  • 联合鼻内芬太尼/一氧化二氮组较单用一氧化二氮组镇静评分更高(2 vs 1,p<0.001),呕吐增加(RR 1.8,95%CI 1.3-2.5),镇静成功率无差异。
  • 无论一氧化二氮浓度或是否联合鼻内芬太尼,均未报告严重不良事件(血氧饱和度下降、呼吸暂停、误吸、心动过缓或低血压);轻微不良事件137例(16.5%)。
  • 呕吐113例(13.6%),与较高一氧化二氮浓度及使用鼻内芬太尼相关,与禁食状态无关;事后分析针对呕吐相关因素。
  • 医生实施与护士实施镇静的不良事件(RR 0.98,95%CI 0.97-1.04)和成功率(RR 0.93,95%CI 0.56-1.7)无差异。

证据类型、等级与局限

  • 证据类型:基于前瞻性收集的镇静登记数据进行的回顾性分析;原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 一氧化二氮可为儿科急诊程序化镇静提供有效镇静,且未记录严重不良事件;联合鼻内芬太尼可能是一种有效的镇静辅助手段,但受呕吐发生率增加的限制(作者认为)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Nitrous oxide (N2O) has multiple benefits in paediatric procedural sedation (PPS), but use is restricted by its limited analgesic properties. Analgesic potency could be increased by combining N2O and intranasal fentanyl (INF). We assessed safety and efficacy data from 10 years (2011-2021) of our N2O PPS programme.

METHODS: Prospectively collected data from a sedation registry at a paediatric emergency department (PED) were reviewed. Total procedures performed with N2O alone or with INF, success rate, sedation depth and adverse events were determined. Contributing factors for these outcomes were assessed via regression analysis and compared between different N2O concentrations, N2O in combination with INF, and for physician versus nurse administered sedation. A post hoc analysis on factors associated with vomiting was also performed.

RESULTS: 831 N2O procedural sedations were performed, 358 (43.1%) involved a combination INF and N2O. Nurses managed sedation in 728 (87.6%) cases. Median sedation depth on the University of Michigan Sedation Scale was 1 (IQR 1-2). Sedation was successful in 809 (97.4%) cases. Combination INF/N2O demonstrated higher median sedation scores (2 vs 1, p<0.001) and increased vomiting (RR 1.8, 95% CI 1.3 to 2.5), with no difference in sedation success compared with N2O alone. No serious adverse events (SAEs) were reported (desaturation, apnoea, aspiration, bradycardia or hypotension) regardless of N2O concentration or use of INF. 137 (16.5%) minor adverse events occurred. Vomiting occurred in 113 (13.6%) cases and was associated with higher concentrations of N2O and INF use, but not associated with fasting status. There were no differences in adverse events (RR 0.98, 95% CI 0.97 to 1.04) or success rates (RR 0.93, 95% CI 0.56 to 1.7) between physician provided and nurse provided sedation.

CONCLUSION: N2O can provide effective PED PPS. No SAEs were recorded. INF may be an effective PPS adjunct but remains limited by increased rates of vomiting.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Croughan S, Barrett M, O'Sullivan R, et al. Safety and efficacy of a nitrous oxide procedural sedation programme in a paediatric emergency department: a decade of outcomes. Emerg Med J. 2024. PMID: 38123983. doi:10.1136/emermed-2022-212931

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。